Serum Markers Predicting Early Non-Responsiveness to Infliximab in Rheumatoid Arthritis: Tumor Necrosis Factor (TNF)-Alpha, TNFRII, and Interleukin (IL)-17 As Potential Indicators. IRAQI JMS 2025, 23 (1). https://doi.org/10.22578/qchesh02.